LOC148189 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.061000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.979200E-01
Normal-vs-Stage2
3.979000E-01
Normal-vs-Stage3
1.463780E-01
Normal-vs-Stage4
7.460200E-01
Stage1-vs-Stage2
5.572800E-01
Stage1-vs-Stage3
1.042570E-01
Stage1-vs-Stage4
3.271800E-01
Stage2-vs-Stage3
2.566200E-01
Stage2-vs-Stage4
1.656610E-01
Stage3-vs-Stage4
7.336300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.106600E-01
Normal-vs-AfricanAmerican
5.118800E-01
Normal-vs-Asian
2.915000E-01
Caucasian-vs-AfricanAmerican
8.941800E-01
Caucasian-vs-Asian
3.681800E-01
AfricanAmerican-vs-Asian
4.617600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.378600E-01
Normal-vs-Female
5.931800E-01
Male-vs-Female
3.998800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.576800E-01
Normal-vs-Age(41-60Yrs)
8.905200E-01
Normal-vs-Age(61-80Yrs)
3.572200E-01
Normal-vs-Age(81-100Yrs)
2.837500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.150600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.260400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.739500E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.747600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.447100E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.420300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.578200E-01
Normal-vs-Daily Drinker
4.499600E-01
Normal-vs-Weekly Drinker
1.616420E-01
Normal-vs-Occasional Drinker
7.923400E-01
Normal-vs-Social Drinker
9.616200E-01
Non Drinker-vs-Daily Drinker
6.133800E-01
Non Drinker-vs-Weekly Drinker
9.533800E-01
Non Drinker-vs-Occasional Drinker
7.744400E-02
Non Drinker-vs-Social Drinker
1.433220E-01
Daily Drinker-vs-Weekly Drinker
7.063400E-01
Daily Drinker-vs-Occasional Drinker
3.359600E-01
Daily Drinker-vs-Social Drinker
2.717600E-01
Weekly Drinker-vs-Occasional Drinker
1.678370E-01
Weekly Drinker-vs-Social Drinker
1.664990E-01
Occasional Drinker-vs-Social Drinker
7.682600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.260590E-01
Normal-vs-Grade 2
1.140440E-03
Normal-vs-Grade 3
3.008100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.064000E-01
Grade 1-vs-Grade 3
4.739600E-01
Grade 1-vs-Grade 4
1.260590E-01
Grade 2-vs-Grade 3
6.343800E-01
Grade 2-vs-Grade 4
1.140440E-03
Grade 3-vs-Grade 4
3.008100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.837400E-01
Normal-vs-NonDiabetic
5.928600E-01
Diabetic-vs-NonDiabetic
1.887010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.292400E-01
Normal-vs-NoPancreatitis
4.995800E-01
Pancreatitis-vs-NoPancreatitis
6.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.327600E-01
Normal-vs-N1
4.673600E-01
N0-vs-N1
7.548000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.734600E-01
Normal-vs-TP53-NonMutant
5.874600E-01
TP53-Mutant-vs-TP53-NonMutant
9.936200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
